Kathryn is currently a strategic advisor in the life sciences sector. She has over twenty years of experience in the field of biotechnology innovation, venture financing and health technology commercialization. Kathryn has held senior positions with Ontario Genomics and the Ontario Personalized Medicine Network. In addition, she was President and CEO of Light Matter Interaction (formerly Attodyne Inc.), a Toronto start-up medical/industrial device company and was Chief Operating Officer of University Medical Discoveries. Kathryn also spent six years in the biotechnology industrial sector as a research scientist at NPS Allelix Inc.
Kathryn earned her Master’s and PhD degrees from the University of Toronto, and an Hon. B.Sc. from Western University.
